These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The 50th anniversary of the Kefauver-Harris Amendments: efficacy assessment and the randomized clinical trial. Turner JR J Clin Hypertens (Greenwich); 2012 Nov; 14(11):810-5. PubMed ID: 23126358 [No Abstract] [Full Text] [Related]
4. Frances Kelsey honored for FDA legacy: award notes her work on thalidomide, clinical trials. Kuehn BM JAMA; 2010 Nov; 304(19):2109-10, 2112. PubMed ID: 21081717 [No Abstract] [Full Text] [Related]
5. Thalidomide in America: a brush with tragedy. McFadyen RE Clio Med; 1976 Jul; 11(2):79-93. PubMed ID: 61093 [No Abstract] [Full Text] [Related]
6. Thalidomide, the FDA, and us -- what do you have? Underground compassionate use. Food and Drug Administration. Notes Undergr; 1995; (no 29):1-3, 8. PubMed ID: 11362280 [TBL] [Abstract][Full Text] [Related]
7. [On the history of the Contergan (thalidomide) catastrophe in the light of drug legislation]. Maio G Dtsch Med Wochenschr; 2001 Oct; 126(42):1183-6. PubMed ID: 11607860 [No Abstract] [Full Text] [Related]
8. Teratology Society 1998 Public Affairs Committee Symposium: the new thalidomide era: dealing with the risks. Friedman JM; Kimmel CA Teratology; 1999 Feb; 59(2):120-3. PubMed ID: 10069442 [No Abstract] [Full Text] [Related]
9. The rehabilitation of thalidomide. MacDougall DS J Int Assoc Physicians AIDS Care; 1998 Jan; 4(1):26-33. PubMed ID: 11365029 [TBL] [Abstract][Full Text] [Related]
10. Thalidomide, drug safety and early drug regulation in the UK. Shah RR Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):199-255. PubMed ID: 11770171 [No Abstract] [Full Text] [Related]
11. Drug labeling for teratogenicity: requirements of the U.S. Food and Drug Administration. Kelsey FO Prog Clin Biol Res; 1985; 163C():155-9. PubMed ID: 3991617 [No Abstract] [Full Text] [Related]
14. [Risk Management of Teratogenic Drugs ~The Current States of Practice in Europe, US and Japan~]. Takagi T; van Bennekom C; Amann S; Hattori C; Shirakuni Y; Sato T; Nasu M Yakugaku Zasshi; 2015; 135(10):1161-8. PubMed ID: 26234426 [TBL] [Abstract][Full Text] [Related]
15. Learning about the safety of drugs--a half-century of evolution. Avorn J N Engl J Med; 2011 Dec; 365(23):2151-3. PubMed ID: 22150034 [No Abstract] [Full Text] [Related]
16. Challenges of thalidomide distribution in a hospital setting. Keravich DP; Daniels CE Am J Health Syst Pharm; 1999 Sep; 56(17):1721-5. PubMed ID: 10512502 [TBL] [Abstract][Full Text] [Related]
17. Frances Oldham Kelsey. FDA medical reviewer leaves her mark on history. Bren L FDA Consum; 2001; 35(2):24-9. PubMed ID: 11444245 [No Abstract] [Full Text] [Related]
18. New drug development. Taylor WJ Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):105-13. PubMed ID: 4895441 [No Abstract] [Full Text] [Related]